Kazia Therapeutics Limited Gains 58.7%
Thu, Oct 17, 2024 at 07:43 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) soared at $0.53, representing a gain of 58.7%. On Thu, Oct 17, 2024, KZIA:NASDAQ touched a New 2-Week High of $0.53. The stock got featured on our News Catalysts scanner on Tue, Oct 15, 2024 at 07:38 AM in the 'BIOTECH' category. From Thu, Oct 03, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Jul 11, 2024 at $1.58 with a volume of 226M+.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Molecular Templates, Inc. (MTEM:NASDAQ), 186.15%
- NKGen Biotech Inc. (NKGN:NASDAQ), 154.08%
- JIADE LIMITED (JDZG:NASDAQ), 136.11%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 68.12%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 58.7%
- Notable Labs Inc Ord (NTBL:NASDAQ), 57.02%
- ShiftPixy, Inc. (PIXY:NASDAQ), 53.45%
- Brera Holdings PLC (BREA:NASDAQ), 46.43%
- Samfine Creation Holdings Group Limited (SFHG:NASDAQ), 44.98%
- Talphera Inc Com (TLPH:NASDAQ), 39.34%